Article Sidebar

Download
View Full Article S.I.S
Statistic
Read Counter : 76 Download : 84

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Main Article Content

Abstract

This study deals with the review of various literature relating to the topic under study, and has been sub-sectioned in accordance as follow key concepts of cerebral toxoplasmosis in HIV, risk factors of cerebral toxoplasmosis, preventive measures against cerebral toxoplasmosis, challenges of HIV patients with adherence to preventive measures, pitfalls in health care affecting the implementation of preventive measures, and theoretical framework. However, Factors affecting HIV clients' exposures and adherence to toxoplasmosis preventive measures can be categorized into individual, interpersonal, community, and institutional levels. These factors influence the extent to which HIV clients are exposed to toxoplasmosis and their willingness and ability to follow preventive measures. Based on research works on resistance patterns done in various parts of the West African sub-region, there has been an increasing worry over how effective co-trimoxazole is as a prophylactic medication against bacterial and parasitic opportunistic infections in HIV patients. CNS manifestations are often the primary feature of HIV/AIDS that leads to its diagnosis in an estimated 1 in 10 patients presenting with neurologic disorders. In late-stage HIV disease, CNS disorders are often associated with poorer outcomes.

Keywords

preventive measures interpersonal community and institutional levels

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
Owusu, A., & Abebrese, J. (2023). Factors Affecting HIV Clients’ Exposures and Adherence to Toxoplasmosis Preventive Measures at the Individual, Interpersonal, Community and Institutional Levels: A Literature Review . Journal of Engineering Applied Science and Humanities, 8(3), 179–201. https://doi.org/10.53075/Ijmsirq/65887879876
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Abuelezam, N., McCormick, A., Surface, E., Fussell, T., Freedberg, K., Lipsitch, M., & Seage, G. (2019). Modelling the epidemiologic impact of achieving UNAIDS fast-track 90-90-90 and 95-95-95 targets in South Africa. Epidemiology & Infection, 147.
  2. Addo, B., Sencherey, S., & Babayara, M. N. (2018). Medication noncompliance among patients with chronic diseases attending a primary health facility in a Periurban district in Ghana. International Journal of Chronic Diseases, 2018.
  3. Addo, S. A., Abdulai, M., Yawson, A., Baddoo, A. N., Zhao, J., Workneh, N., Okae, I., & Wiah, E. (2018). Availability of HIV services along the continuum of HIV testing, care and treatment in Ghana. BMC Health Services Research, 18(1), 1–10.
  4. Agrawal, D., & Hussain, N. (2005). Decompressive craniectomy in cerebral toxoplasmosis. European Journal of Clinical Microbiology and Infectious Diseases, 24(11), 772–773.
  5. Amankwah, A. K. (2015). Facilitators and Barriers to Antiretroviral Therapy Adherence among Hiv/Aids Patients: A Multi-Case Study Of Sunyani Regional and Municipal Hospitals.
  6. Ammon, N., Mason, S., & Corkery, J. (2018). Factors affecting antiretroviral therapy adherence among human immunodeficiency virus–positive adolescents in Sub-Saharan Africa: A systematic review. Public Health, 157, 20–31.
  7. Ankrah, D. N., Koster, E. S., Mantel-Teeuwisse, A. K., Arhinful, D. K., Agyepong, I. A., & Lartey, M. (2016a). Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana. Patient Preference and Adherence, 10, 329.
  8. Ankrah, D. N., Koster, E. S., Mantel-Teeuwisse, A. K., Arhinful, D. K., Agyepong, I. A., & Lartey, M. (2016b). Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana. Patient Preference and Adherence, 10, 329.
  9. Arefkhah, N., Sarkari, B., Afrashteh, M., Rezaei, Z., & Dehghani, M. (2018). Toxoplasma gondii: The prevalence and risk factors in HIV-infected patients in Fars province, southern Iran. Iranian Red Crescent Medical Journal, 20(6).
  10. Audain, K. A., Zotor, F. B., Amuna, P., & Ellahi, B. (2015). Food supplementation among HIV-infected adults in Sub-Saharan Africa: Impact on treatment adherence and weight gain. Proceedings of the Nutrition Society, 74(4), 517–525. https://doi.org/10.1017/S0029665115000063
  11. Azovtseva, O., Viktorova, E., Bakulina, E., Shelomov, A., & Trofimova, T. (2020). Cerebral toxoplasmosis in HIV-infected patients over 2015–2018 (a case study of Russia). Epidemiology & Infection, 148.
  12. Bamba, S., Zoungrana, J., Nikièma, Z., Sondo, A. K., Ndiaye, J.-L., & Bretagne, S. (2017). Impact of alternative treatment approach for cerebral toxoplasmosis among HIV/AIDS patients from a resourcepoor setting in Burkina Faso. Annals of Parasitology, 63(3).
  13. Basavaraju, A. (2016). Toxoplasmosis in HIV infection: An overview. Tropical Parasitology, 6(2), 129.
  14. Bedu-Addo, G. (2006). Cerebral toxoplasmosis in HIV/AIDS: A case report. West African Journal of Medicine, 25(3), 252–253.
  15. Bhatti, A. B., Usman, M., Kandi, V., Bhatti, A. B., Usman, M., & Kandi, V. (2016). Current Scenario of HIV/AIDS, Treatment Options, and Major Challenges with Compliance to Antiretroviral Therapy. Cureus, 8(3). https://doi.org/10.7759/cureus.515
  16. Boakye, D. S., & Mavhandu-Mudzusi, A. H. (2019). Nurses knowledge, attitudes and practices towards patients with HIV and AIDS in Kumasi, Ghana. International Journal of Africa Nursing Sciences, 11, 100147. https://doi.org/10.1016/j.ijans.2019.05.001
  17. Carlucci, J. G., Kamanga, A., Sheneberger, R., Shepherd, B. E., Jenkins, C. A., Spurrier, J., & Vermund, S. H. (2008). Predictors of Adherence to Antiretroviral Therapy in Rural Zambia. JAIDS Journal of Acquired Immune Deficiency Syndromes, 47(5), 615–622. https://doi.org/10.1097/QAI.0b013e318165dc25
  18. Central Limit Theorem. (2017). Retrieved 11 February 2022, from https://sphweb.bumc.bu.edu/otlt/mph-modules/bs/bs704_probability/BS704_Probability12.html
  19. Central Limit Theorem Explained—Statistics By Jim. (2020). Retrieved 13 February 2022, from https://statisticsbyjim.com/basics/central-limit-theorem/
  20. CNS Toxoplasmosis in HIV: Overview, Pathophysiology, Epidemiology. (2021). https://emedicine.medscape.com/article/1167298-overview
  21. Connolly, M. P., Haitsma, G., Hernández, A. V., & Vidal, J. E. (2017). Systematic review and meta-analysis of secondary prophylaxis for prevention of HIV-related toxoplasmic encephalitis relapse using trimethoprim-sulfamethoxazole. Pathogens and Global Health, 111(6), 327–331. https://doi.org/10.1080/20477724.2017.1377974
  22. Cook to a Safe Minimum Internal Temperature | FoodSafety.gov. (2019). Retrieved 8 March 2023, from https://www.foodsafety.gov/food-safety-charts/safe-minimum-internal-temperatures
  23. Dai, L., Mahajan, S. D., Guo, C., Zhang, T., Wang, W., Li, T., Jiang, T., Wu, H., & Li, N. (2014). Spectrum of central nervous system disorders in hospitalized HIV/AIDS patients (2009–2011) at a major HIV/AIDS referral center in Beijing, China. Journal of the Neurological Sciences, 342(1–2), 88–92.
  24. Dubey, J. (2004). Toxoplasmosis–a waterborne zoonosis. Veterinary Parasitology, 126(1–2), 57–72.
  25. Dubey, J. P., Hill, D. E., Jones, J. L., Hightower, A. W., Kirkland, E., Roberts, J. M., Marcet, P. L., Lehmann, T., Vianna, M. C. B., Miska, K., Sreekumar, C., Kwok, O. C. H., Shen, S. K., & Gamble, H. R. (2005a). PREVALENCE OF VIABLE TOXOPLASMA GONDII IN BEEF, CHICKEN, AND PORK FROM RETAIL MEAT STORES IN THE UNITED STATES: RISK ASSESSMENT TO CONSUMERS. Journal of Parasitology, 91(5), 1082–1093. https://doi.org/10.1645/GE-683.1
  26. Dubey, J. P., Hill, D. E., Jones, J. L., Hightower, A. W., Kirkland, E., Roberts, J. M., Marcet, P. L., Lehmann, T., Vianna, M. C. B., Miska, K., Sreekumar, C., Kwok, O. C. H., Shen, S. K., & Gamble, H. R. (2005b). PREVALENCE OF VIABLE TOXOPLASMA GONDII IN BEEF, CHICKEN, AND PORK FROM RETAIL MEAT STORES IN THE UNITED STATES: RISK ASSESSMENT TO CONSUMERS. Journal of Parasitology, 91(5), 1082–1093. https://doi.org/10.1645/GE-683.1
  27. Dunay, I. R., Gajurel, K., Dhakal, R., Liesenfeld, O., & Montoya, J. G. (2018). Treatment of toxoplasmosis: Historical perspective, animal models, and current clinical practice. Clinical Microbiology Reviews, 31(4), e00057-17.
  28. Dzansi, G., Tornu, E., & Chipps, J. (2020). Promoters and inhibitors of treatment adherence among HIV/AIDS patients receiving antiretroviral therapy in Ghana: Narratives from an underserved population. PloS One, 15(3), e0230159.
  29. Elsheikha, H. M., Marra, C. M., & Zhu, X.-Q. (2020). Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis. Clinical Microbiology Reviews, 34(1), e00115-19.
  30. Errata: Evaluation of co-trimoxazole Adherence in Infants of HIV Positive Mothers aged 6 weeks to 6 months in Lagos Nigeria. Nigerian Hospital Practice, 23(4–5), Article 4–5. https://doi.org/10.4314/nhp.v23i4-5.
  31. Eshun-Wilson, I., Rohwer, A., Hendricks, L., Oliver, S., & Garner, P. (2019). Being HIV positive and staying on antiretroviral therapy in Africa: A qualitative systematic review and theoretical model. PloS One, 14(1), e0210408.
  32. Fadeyi, I., Lalani, M., Mailk, N., Wyk, A. V., & Kaur, H. (2015). Quality of the Antibiotics—Amoxicillin and Co-Trimoxazole from Ghana, Nigeria, and the United Kingdom. The American Journal of Tropical Medicine and Hygiene, 92(Suppl 6), 87–94. https://doi.org/10.4269/ajtmh.14-0539
  33. Ghana Districts: A repository of all Local Assemblies in Ghana. (2015). Retrieved 8 October 2021, from https://www.ghanadistricts.com/Home/District/50
  34. Global HIV Programme. (2021). Retrieved 28 October 2021, from https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics
  35. Goal 3 | Department of Economic and Social Affairs. (2017). Retrieved 8 February 2022, from https://sdgs.un.org/goals/goal3
  36. https://doi.org/10.1177/1090198111418634
  37. HIV/AIDS. (n.d.). Retrieved 01 April 2023, from https://www.who.int/health-topics/hiv-aids
  38. Irungu, B. N., Koech, L. C., Ondicho, J. M., & Keter, L. K. (2021). Quality assessment of selected co-trimoxazole suspension brands marketed in Nairobi County, Kenya. PLOS ONE, 16(9), e0257625. https://doi.org/10.1371/journal.pone.0257625
  39. Kelly, M., McCarthy, S., & Sahm, L. J. (2014). Knowledge, attitudes and beliefs of patients and carers regarding medication adherence: A review of qualitative literature. European Journal of Clinical Pharmacology, 70(12), 1423–1431.
  40. Kijlstra, A., & Jongert, E. (2008a). Control of the risk of human toxoplasmosis transmitted by meat. International Journal for Parasitology, 38(12), 1359–1370. https://doi.org/10.1016/j.ijpara.2008.06.002
  41. Kijlstra, A., & Jongert, E. (2008b). Control of the risk of human toxoplasmosis transmitted by meat. International Journal for Parasitology, 38(12), 1359–1370. https://doi.org/10.1016/j.ijpara.2008.06.002
  42. Kirk, O., Lundgren, J. D., Nielsen, H., & Gerstoft, J. (1999). Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy? Aids, 13(13), 1647–1651.
  43. Kongsaengdao, S., Samintarapanya, K., Oranratnachai, K., Prapakarn, W., & Apichartpiyakul, C. (2008). Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients. Journal of the International Association of Physicians in AIDS Care, 7(1), 11–16.
  44. Kumarasamy, N., Safren, S. A., Raminani, S. R., Pickard, R., James, R., Krishnan, A. S., Solomon, S., & Mayer, K. H. (2005). Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: A qualitative study. AIDS Patient Care & STDs, 19(8), 526–537.
  45. Lee, G. T., Antelo, F., & Mlikotic, A. A. (2009). Cerebral toxoplasmosis. Radiographics, 29(4), 1200–1205.
  46. Luma, H. N., Tchaleu, B. C. N., Mapoure, Y. N., Temfack, E., Doualla, M. S., Halle, M. P., Joko, H. A., & Koulla-Shiro, S. (2013). Toxoplasma encephalitis in HIV/AIDS patients admitted to the Douala general hospital between 2004 and 2009: A cross sectional study. BMC Research Notes, 6(1), 1–5.
  47. MacCarthy, S., Saya, U., Samba, C., Birungi, J., Okoboi, S., & Linnemayr, S. (2018). “How am I going to live?”: Exploring barriers to ART adherence among adolescents and young adults living with HIV in Uganda. BMC Public Health, 18(1), 1158. https://doi.org/10.1186/s12889-018-6048-7
  48. Matheus, M., Serrat, A., Vante, I., & Shinde, A. (2021). Anisocoria, An Unusual Physical Exam Finding Leading To A Concurrent Diagnosis Of Cerebral Toxoplasmosis And Hiv/Aids. Journal of Infectious Diseases & Case Reports. SRC/JIDSCR-152. DOI: Https://Doi. Org/10.47363/JIDSCR/2021 (2), 137, 3.
  49. Mboera, L. E. G., Kishamawe, C., Kimario, E., & Rumisha, S. F. (2019). Mortality Patterns of Toxoplasmosis and Its Comorbidities in Tanzania: A 10-Year Retrospective Hospital-Based Survey. Frontiers in Public Health, 7, 25. https://doi.org/10.3389/fpubh.2019.00025
  50. Medication Adherence: The Elephant in the Room. (2018). Retrieved 25 March 2023, from https://www.uspharmacist.com/article/medication-adherence-the-elephant-in-the-room
  51. Moriarty, K., Genberg, B., Norman, B., & Reece, R. (2018). The effect of antiretroviral stock-outs on medication adherence among patients living with HIV in Ghana: A qualitative study. Journal of the Association of Nurses in AIDS Care, 29(2), 231–240.
  52. Mukui, I. N., Ng’ang’a, L., Williamson, J., Wamicwe, J. N., Vakil, S., Katana, A., & Kim, A. A. (2016). Rates and Predictors of Non-Adherence to Antiretroviral Therapy among HIV-Positive Individuals in Kenya: Results from the Second Kenya AIDS Indicator Survey, 2012. PLOS ONE, 11(12), e0167465. https://doi.org/10.1371/journal.pone.0167465
  53. Müller, P., & Velez Lapão, L. (2021). Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid – preventive therapies for people living with HIV [Preprint]. HIV/AIDS. https://doi.org/10.1101/2021.04.30.21256370
  54. Navia, B. A., Petito, C. K., Gold, J. W., Cho, E., Jordan, B. D., & Price, R. W. (1986). Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patients. Annals of Neurology, 19(3), 224–238.
  55. Obirikorang, C., Selleh, P. K., Abledu, J. K., & Fofie, C. O. (2013). Predictors of adherence to antiretroviral therapy among HIV/AIDS patients in the upper west region of Ghana. International Scholarly Research Notices, 2013.
  56. Ogendi, E., Maina, N., Kagira, J., Ngotho, M., Mbugua, G., & Karanja, S. (2013a). Questionnaire Survey on the Occurrence of Risk factors for Toxoplasma gondii infection amongst Farmers in Thika District, Kenya. Journal of the South African Veterinary Association, 84(1). https://doi.org/10.4102/jsava.v84i1.191
  57. Ogendi, E., Maina, N., Kagira, J., Ngotho, M., Mbugua, G., & Karanja, S. (2013b). Questionnaire Survey on the Occurrence of Risk factors for Toxoplasma gondii infection amongst Farmers in Thika District, Kenya. Journal of the South African Veterinary Association, 84(1). https://doi.org/10.4102/jsava.v84i1.191
  58. Opintan, J. A., Awadzi, B. K., Biney, I. J., Ganu, V., Doe, R., Kenu, E., Adu, R. F., Osei, M. M., Akumwena, A., & Grigg, M. E. (2017). High rates of cerebral toxoplasmosis in HIV patients presenting with meningitis in Accra, Ghana. Transactions of The Royal Society of Tropical Medicine and Hygiene, 111(10), 464–471.
  59. Owusu, A. Y. (2020). Social contexts of living with HIV/AIDS in the Eastern Region of Ghana. Istanbul University Journal of Sociology, 39(2), 425–454.
  60. Pappoe, F., Cheng, W., Wang, L., Li, Y., Obiri-Yeboah, D., Nuvor, S. V., Ambachew, H., Hu, X., Luo, Q., & Chu, D. (2017). Prevalence of Toxoplasma gondii infection in HIV-infected patients and food animals and direct genotyping of T. gondii isolates, Southern Ghana. Parasitology Research, 116(6), 1675–1685.
  61. Pereira, K. S., Franco, R. M. B., & Leal, D. A. G. (2010a). Transmission of Toxoplasmosis (Toxoplasma gondii) by Foods. In Advances in Food and Nutrition Research (Vol. 60, pp. 1–19). Elsevier. https://doi.org/10.1016/S1043-4526(10)60001-0
  62. Pereira, K. S., Franco, R. M., & Leal, D. A. (2010b). Transmission of toxoplasmosis (Toxoplasma gondii) by foods. Advances in Food and Nutrition Research, 60, 1–19.
  63. Pereira-Chioccola, V. L., Vidal, J. E., & Su, C. (2009). Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients. Future Microbiology, 4(10), 1363–1379.
  64. Prah, J., Hayfron-Benjamin, A., Abdulai, M., Lasim, O., & Nartey, Y. (2018). Factors affecting adherence to antiretroviral therapy among HIV/AIDS patients in cape coast metropolis. Ghana J HIV AIDS, 4(1).
  65. Prevention, C.-C. for D. C. and. (2019, February 28).
  66. CDC - Toxoplasmosis—Epidemiology & Risk Factors. https://www.cdc.gov/parasites/toxoplasmosis/epi.html
  67. Reda, A. A., & Biadgilign, S. (2012). Determinants of Adherence to Antiretroviral Therapy among HIV-Infected Patients in Africa. AIDS Research and Treatment, 2012, e574656. https://doi.org/10.1155/2012/574656
  68. Rostami, A., Keshavarz, H., Shojaee, S., Mohebali, M., & Meamar, A. R. (2014). Frequency of Toxoplasma gondii in HIV Positive Patients from West of Iran by ELISA and PCR. 9(4), 8.
  69. Saavedra, A., Campinha-Bacote, N., Hajjar, M., Kenu, E., Gillani, F. S., Obo-Akwa, A., Lartey, M., & Kwara, A. (2017). Causes of death and factors associated with early mortality of HIV-infected adults admitted to Korle-Bu Teaching Hospital. Pan African Medical Journal, 27(1).
  70. Scott Sutton, S., Magagnoli, J., & Hardin, J. W. (2016).
  71. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 36(4), 385–401. https://doi.org/10.1002/phar.1728
  72. Smurzynski, M., Wu, K., Benson, C. A., Bosch, R. J., Collier, A. C., & Koletar, S. L. (2010a). Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS defining events among persons followed in the ACTG Longitudinal Linked Randomized Trials (ALLRT) study. Journal of Acquired Immune Deficiency Syndromes (1999), 55(1), 117.
  73. Smurzynski, M., Wu, K., Benson, C. A., Bosch, R. J., Collier, A. C., & Koletar, S. L. (2010b). Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS defining events among persons followed in the ACTG Longitudinal Linked Randomized Trials (ALLRT) study. Journal of Acquired Immune Deficiency Syndromes (1999), 55(1), 117.
  74. Social-Ecological Model Offers New Approach to Public Health. (2017, August 5). The Borgen Project. https://borgenproject.org/social-ecological-model/
  75. Soomro, N., Fitzgerald, G., Seeley, J., Schatz, E.,
  76. Nachega, J. B., & Negin, J. (2019). Comparison of antiretroviral therapy adherence among HIV-infected older adults with younger adults in Africa: Systematic review and meta-analysis. AIDS and Behavior, 23(2), 445–458.
  77. Swami, A., Thakuria, R., & Kharat, S. (2015). Cerebral toxoplasmosis in a treatment naive HIV patient with high CD4 count responding to treatment with a regime of cotrimoxazole and pyrimethamine: Do we need to start prophylaxis for toxoplasmosis at a higher CD4 count. HIV/AIDS Research and Treatment, 2(3), 72–75.
  78. Tenter, A. M. (2009). Toxoplasma gondii in animals used for human consumption. Memórias Do Instituto Oswaldo Cruz, 104(2), 364–369. https://doi.org/10.1590/S0074-02762009000200033
  79. Tetteh, R. A., Nartey, E. T., Lartey, M., Yankey, B., Mantel-Teeuwisse, A. K., Leufkens, H. G., Acheampong, F., & Dodoo, A. N. (2018). Knowledge and Attitudes of HIV Infected Patients on the Adverse Effects of Antiretroviral Medicines in Ghana. 117.
  80. Teutsch, S. M., Juranek, D. D., Sulzer, A., Dubey, J. P., & Sikes, R. K. (1979). Epidemic Toxoplasmosis Associated with Infected Cats. New England Journal of Medicine, 300(13), 695–699. https://doi.org/10.1056/NEJM197903293001302
  81. Yohanes, T., Debalke, S., & Zemene, E. (2014).
  82. Latent Toxoplasma gondii infection and associated risk factors among HIV-infected individuals at Arba Minch Hospital, South Ethiopia. AIDS Research and Treatment, 2014.
  83. Zachariah, R., Ford, N., Philips, M., S.Lynch,
  84. Massaquoi, M., Janssens, V., & Harries, A. D. (2009). Task shifting in HIV/AIDS: Opportunities, challenges and proposed actions for sub-Saharan Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 103(6), 549–558. https://doi.org/10.1016/j.trstmh.2008.09.019